A prognostic score for patients with intermediate-stage hepatocellular carcinoma treated with transarterial chemoembolization

Intermediate-stage hepatocellular carcinoma (HCC), defined according to the Barcelona Clinic Liver Cancer (BCLC) staging system, is a heterogeneous condition with variable clinical benefits from transarterial chemoembolization (TACE). This study aimed to develop a simple validated prognostic score b...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	PloS one 2015-04, Vol.10 (4), p.e0125244-e0125244
Hauptverfasser:	Ogasawara, Sadahisa, Chiba, Tetsuhiro, Ooka, Yoshihiko, Kanogawa, Naoya, Motoyama, Tenyu, Suzuki, Eiichiro, Tawada, Akinobu, Azemoto, Ryosaku, Shinozaki, Masami, Yoshikawa, Masaharu, Yokosuka, Osamu
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Aspartate Aspartate aminotransferase C-reactive protein Carcinoma, Hepatocellular - blood supply Carcinoma, Hepatocellular - mortality Carcinoma, Hepatocellular - pathology Carcinoma, Hepatocellular - therapy Care and treatment Chemoembolization Chemoembolization, Therapeutic Creatinine Datasets Development and progression Etiology Female Gastroenterology Hepatitis C virus Hepatocellular carcinoma Hospitals Humans Kaplan-Meier Estimate Lesions Liver Liver cancer Liver Neoplasms - blood supply Liver Neoplasms - mortality Liver Neoplasms - pathology Liver Neoplasms - therapy Male Medical prognosis Medicine Multivariate Analysis Neoplasm Staging Nephrology Patients Pretreatment Prognosis Proteins Regression analysis Regression models Reproducibility of Results Ribonucleic acid RNA Statistical analysis Survival Survival analysis Tomography Training Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!